MacroGenics IncNASDAQ:MGNX
- LAST PRICE4.2900
- TODAY'S CHANGE (%)-0.2100 (-4.6667%)
- Bid / Lots4.2600/ 3
- Ask / Lots4.3600/ 1
- Open / Previous Close4.4800 / 4.5000
- Day Range
- 52 Week Range
- Volume1,249,375
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGNX |
|---|---|---|
| 09:32 ET | 6322 | 4.46 |
| 09:34 ET | 1700 | 4.435 |
| 09:36 ET | 1232 | 4.43 |
| 09:38 ET | 1200 | 4.42 |
| 09:39 ET | 401 | 4.42 |
| 09:41 ET | 3428 | 4.4051 |
| 09:43 ET | 1411 | 4.41 |
| 09:45 ET | 310 | 4.41 |
| 09:48 ET | 8915 | 4.39 |
| 09:50 ET | 4557 | 4.4 |
| 09:52 ET | 1728 | 4.38 |
| 09:54 ET | 1300 | 4.39 |
| 09:56 ET | 6857 | 4.3688 |
| 09:57 ET | 3374 | 4.39 |
| 09:59 ET | 100 | 4.38 |
| 10:01 ET | 34897 | 4.335 |
| 10:03 ET | 2490 | 4.35 |
| 10:06 ET | 4916 | 4.39 |
| 10:08 ET | 6194 | 4.35 |
| 10:10 ET | 600 | 4.36 |
| 10:12 ET | 6838 | 4.4 |
| 10:14 ET | 300 | 4.38 |
| 10:15 ET | 700 | 4.385 |
| 10:17 ET | 1630 | 4.36 |
| 10:19 ET | 1533 | 4.37 |
| 10:21 ET | 100 | 4.3712 |
| 10:24 ET | 4500 | 4.385 |
| 10:26 ET | 1000 | 4.4 |
| 10:28 ET | 1520 | 4.385 |
| 10:30 ET | 1986 | 4.39 |
| 10:32 ET | 600 | 4.36 |
| 10:33 ET | 537 | 4.35 |
| 10:35 ET | 1500 | 4.35 |
| 10:37 ET | 4361 | 4.36 |
| 10:39 ET | 1224 | 4.38 |
| 10:42 ET | 200 | 4.39 |
| 10:44 ET | 500 | 4.38 |
| 10:46 ET | 500 | 4.38 |
| 10:48 ET | 900 | 4.35 |
| 10:50 ET | 1100 | 4.36 |
| 10:53 ET | 597 | 4.365 |
| 10:55 ET | 1316 | 4.365 |
| 10:57 ET | 3111 | 4.39 |
| 11:00 ET | 28103 | 4.385 |
| 11:02 ET | 22061 | 4.425 |
| 11:04 ET | 2668 | 4.415 |
| 11:06 ET | 5322 | 4.37 |
| 11:08 ET | 6935 | 4.345 |
| 11:09 ET | 6922 | 4.3499 |
| 11:11 ET | 1385 | 4.3502 |
| 11:13 ET | 1400 | 4.35 |
| 11:15 ET | 6010 | 4.355 |
| 11:18 ET | 2209 | 4.38 |
| 11:20 ET | 2104 | 4.37 |
| 11:22 ET | 5878 | 4.37 |
| 11:24 ET | 300 | 4.365 |
| 11:26 ET | 1905 | 4.365 |
| 11:29 ET | 100 | 4.365 |
| 11:31 ET | 6142 | 4.355 |
| 11:33 ET | 1100 | 4.36 |
| 11:36 ET | 3222 | 4.34 |
| 11:38 ET | 5500 | 4.34 |
| 11:40 ET | 12802 | 4.365 |
| 11:42 ET | 30434 | 4.385 |
| 11:44 ET | 4019 | 4.38 |
| 11:45 ET | 1094 | 4.38 |
| 11:47 ET | 1500 | 4.39 |
| 11:49 ET | 6606 | 4.37 |
| 11:51 ET | 900 | 4.375 |
| 11:54 ET | 200 | 4.37 |
| 11:56 ET | 1200 | 4.375 |
| 11:58 ET | 1125 | 4.375 |
| 12:00 ET | 1411 | 4.38 |
| 12:02 ET | 900 | 4.37 |
| 12:03 ET | 19383 | 4.34 |
| 12:05 ET | 1393 | 4.33 |
| 12:07 ET | 850 | 4.3399 |
| 12:09 ET | 1512 | 4.33 |
| 12:12 ET | 28275 | 4.36 |
| 12:14 ET | 300 | 4.35 |
| 12:16 ET | 2981 | 4.33 |
| 12:18 ET | 2179 | 4.325 |
| 12:20 ET | 31315 | 4.366 |
| 12:21 ET | 300 | 4.355 |
| 12:23 ET | 2342 | 4.345 |
| 12:25 ET | 900 | 4.34 |
| 12:27 ET | 6771 | 4.36 |
| 12:30 ET | 2600 | 4.385 |
| 12:32 ET | 4332 | 4.405 |
| 12:34 ET | 10657 | 4.39 |
| 12:36 ET | 5844 | 4.41 |
| 12:38 ET | 3900 | 4.42 |
| 12:39 ET | 3000 | 4.4308 |
| 12:41 ET | 9973 | 4.4199 |
| 12:43 ET | 6332 | 4.43 |
| 12:45 ET | 3492 | 4.43 |
| 12:48 ET | 2823 | 4.4494 |
| 12:50 ET | 4799 | 4.45 |
| 12:52 ET | 4911 | 4.48 |
| 12:54 ET | 3187 | 4.4615 |
| 12:56 ET | 3182 | 4.44 |
| 12:57 ET | 4185 | 4.415 |
| 12:59 ET | 200 | 4.41 |
| 01:01 ET | 1300 | 4.412 |
| 01:03 ET | 1300 | 4.415 |
| 01:06 ET | 1284 | 4.4 |
| 01:08 ET | 3900 | 4.4 |
| 01:10 ET | 7832 | 4.375 |
| 01:12 ET | 1035 | 4.375 |
| 01:14 ET | 110 | 4.375 |
| 01:15 ET | 2800 | 4.38 |
| 01:17 ET | 1644 | 4.375 |
| 01:19 ET | 4932 | 4.375 |
| 01:21 ET | 860 | 4.36 |
| 01:24 ET | 1700 | 4.365 |
| 01:26 ET | 4043 | 4.36 |
| 01:28 ET | 100 | 4.365 |
| 01:30 ET | 1600 | 4.375 |
| 01:32 ET | 3147 | 4.3601 |
| 01:33 ET | 700 | 4.36 |
| 01:35 ET | 100 | 4.365 |
| 01:37 ET | 3406 | 4.355 |
| 01:39 ET | 1147 | 4.35 |
| 01:42 ET | 4141 | 4.33 |
| 01:44 ET | 1300 | 4.325 |
| 01:46 ET | 200 | 4.325 |
| 01:48 ET | 146 | 4.325 |
| 01:50 ET | 1000 | 4.3295 |
| 01:51 ET | 1781 | 4.31 |
| 01:53 ET | 1072 | 4.3 |
| 01:55 ET | 1540 | 4.3 |
| 01:57 ET | 485 | 4.3 |
| 02:00 ET | 3727 | 4.3 |
| 02:02 ET | 100 | 4.305 |
| 02:04 ET | 708 | 4.3 |
| 02:06 ET | 800 | 4.305 |
| 02:08 ET | 300 | 4.3 |
| 02:09 ET | 2008 | 4.29 |
| 02:11 ET | 2137 | 4.285 |
| 02:13 ET | 1331 | 4.3 |
| 02:15 ET | 1999 | 4.305 |
| 02:18 ET | 2500 | 4.3 |
| 02:20 ET | 100 | 4.295 |
| 02:22 ET | 300 | 4.29 |
| 02:24 ET | 300 | 4.295 |
| 02:26 ET | 6847 | 4.28 |
| 02:29 ET | 2000 | 4.285 |
| 02:31 ET | 3141 | 4.27 |
| 02:36 ET | 300 | 4.2612 |
| 02:38 ET | 400 | 4.265 |
| 02:40 ET | 7906 | 4.27 |
| 02:42 ET | 3401 | 4.27 |
| 02:44 ET | 200 | 4.275 |
| 02:45 ET | 1100 | 4.27 |
| 02:47 ET | 931 | 4.275 |
| 02:49 ET | 700 | 4.28 |
| 02:54 ET | 941 | 4.265 |
| 02:56 ET | 112 | 4.27 |
| 02:58 ET | 1211 | 4.26 |
| 03:00 ET | 1687 | 4.255 |
| 03:02 ET | 934 | 4.2588 |
| 03:03 ET | 828 | 4.2565 |
| 03:05 ET | 13121 | 4.295 |
| 03:07 ET | 843 | 4.28 |
| 03:09 ET | 800 | 4.275 |
| 03:12 ET | 3540 | 4.285 |
| 03:14 ET | 1134 | 4.2701 |
| 03:16 ET | 4590 | 4.29 |
| 03:18 ET | 1520 | 4.3 |
| 03:20 ET | 200 | 4.285 |
| 03:21 ET | 400 | 4.28 |
| 03:23 ET | 200 | 4.28 |
| 03:25 ET | 942 | 4.275 |
| 03:27 ET | 2652 | 4.2688 |
| 03:30 ET | 4423 | 4.28 |
| 03:32 ET | 2008 | 4.275 |
| 03:34 ET | 4304 | 4.275 |
| 03:36 ET | 1200 | 4.275 |
| 03:38 ET | 200 | 4.28 |
| 03:39 ET | 2995 | 4.285 |
| 03:41 ET | 1793 | 4.285 |
| 03:43 ET | 1813 | 4.2799 |
| 03:45 ET | 1725 | 4.28 |
| 03:48 ET | 6223 | 4.265 |
| 03:50 ET | 700 | 4.265 |
| 03:52 ET | 3589 | 4.26 |
| 03:54 ET | 63937 | 4.305 |
| 03:56 ET | 4906 | 4.285 |
| 03:57 ET | 13358 | 4.285 |
| 03:59 ET | 124896 | 4.29 |
Today
An Investigation Has Commenced on Behalf of MacroGenics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MGNX Losses., from 5 hours ago by Dow Jones
5 hours ago by Dow JonesInvestors who lost money on MacroGenics, Inc. should contact Levi & Korsinsky about an ongoing investigation - MGNX, from 5 hours ago by Dow Jones
5 hours ago by Dow JonesThe Schall Law Firm Is Initiating A Probe Into Claims Against MacroGenics Inc And Urges Its Shareholders To Make Contact, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
Yesterday
MacroGenics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by MacroGenics, Inc. (MGNX), from 23 hours ago by Dow Jones
23 hours ago by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX, from 23 hours ago by Dow Jones
23 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MacroGenics Inc | 281.9M | -11.4x | --- |
Poseida Therapeutics Inc | 266.6M | -2.2x | --- |
Adaptimmune Therapeutics PLC | 225.0M | -1.2x | --- |
ADC Therapeutics SA | 258.7M | -0.9x | --- |
Innate Pharma SA | 174.0M | -19.8x | --- |
AVITA Medical Inc | 207.9M | -4.5x | --- |
Company Information
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is vobramitamab duocarmazine (vobra duo), an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Its clinical pipeline includes two product candidates based on its, bispecific DART technology that co-engages both PD-1 and other checkpoint molecules. These candidates include lorigerlimab and tebotelimab. In addition, it is developing MGD024, a bispecific DART molecule. It is also developing various other programs.
Contact Information
- Headquarters
- 9704 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 301-251-5172
- Fax
- 301-251-5321
Executives
- Independent Chairman of the Board
- William Heiden
- President, Chief Executive Officer, Director
- Scott Koenig
- Chief Financial Officer, Senior Vice President, Corporate Secretary
- James Karrels
- Chief Operating Officer
- Eric Risser
- Senior Vice President - Research, Chief Scientific Officer
- Ezio Bonvini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $281.9M |
|---|---|
Revenue (TTM) | $43.4M |
Shares Outstanding | 62.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.08 |
EPS | $-0.38 |
Book Value | $2.46 |
P/E Ratio | -11.4x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -75.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
